These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24117204)

  • 1. Proteomics and metabolomics in cancer drug development.
    D'Alessandro A; Zolla L
    Expert Rev Proteomics; 2013 Oct; 10(5):473-88. PubMed ID: 24117204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics revisits the cancer metabolome.
    Hu H; Deng C; Yang T; Dong Q; Chen Y; Nice EC; Huang C; Wei Y
    Expert Rev Proteomics; 2011 Aug; 8(4):505-33. PubMed ID: 21819305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research progresses on the role of cell autophagy in cancer].
    Li GD; Wu DQ; Li BY
    Ai Zheng; 2009 Apr; 28(4):445-8. PubMed ID: 19622310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and autophagy in cancer: guardian of the genome meets guardian of the proteome.
    Ryan KM
    Eur J Cancer; 2011 Jan; 47(1):44-50. PubMed ID: 21112207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant GnRH-p53 protein sensitizes breast cancer cells to 5-fluorouracil-induced apoptosis in vitro and in vivo.
    Lu Y; Zhang Z; Yan Z; Chen L; Deng W; Lotze M; Wang Z; Lin X; Li LY
    Apoptosis; 2013 Oct; 18(10):1214-23. PubMed ID: 23801079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The redox protein HMGB1 regulates cell death and survival in cancer treatment.
    Tang D; Loze MT; Zeh HJ; Kang R
    Autophagy; 2010 Nov; 6(8):1181-3. PubMed ID: 20861675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROS, autophagy, mitochondria and cancer: Ras, the hidden master?
    Bellot GL; Liu D; Pervaiz S
    Mitochondrion; 2013 May; 13(3):155-62. PubMed ID: 22750269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics and cancer drug discovery: let the cells do the talking.
    D'Alessandro A; Zolla L
    Drug Discov Today; 2012 Jan; 17(1-2):3-9. PubMed ID: 22001601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systems biology analysis of autophagy in cancer therapy.
    Shi Z; Li CY; Zhao S; Yu Y; An N; Liu YX; Wu CF; Yue BS; Bao JK
    Cancer Lett; 2013 Sep; 337(2):149-60. PubMed ID: 23791881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA regulation of core apoptosis pathways in cancer.
    Lima RT; Busacca S; Almeida GM; Gaudino G; Fennell DA; Vasconcelos MH
    Eur J Cancer; 2011 Jan; 47(2):163-74. PubMed ID: 21145728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-targeted cancer pharmacotherapy: move towards small molecule compounds.
    Kim SH; Dass CR
    J Pharm Pharmacol; 2011 May; 63(5):603-10. PubMed ID: 21492161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic approaches to overcoming chemoresistance in ovarian cancer.
    Suh DH; Kim MK; No JH; Chung HH; Song YS
    Ann N Y Acad Sci; 2011 Jul; 1229():53-60. PubMed ID: 21793839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncometabolomics in cancer research.
    Gupta S; Chawla K
    Expert Rev Proteomics; 2013 Aug; 10(4):325-36. PubMed ID: 23992416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the messengers of death: the advent of selective activation of apoptosis for cancer therapy.
    Bremer E; Helfrich W
    Discov Med; 2006 Jun; 6(33):113-7. PubMed ID: 17234145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncometabolites-driven tumorigenesis: From genetics to targeted therapy.
    Morin A; Letouzé E; Gimenez-Roqueplo AP; Favier J
    Int J Cancer; 2014 Nov; 135(10):2237-48. PubMed ID: 25124653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics in cell culture--a strategy to study crucial metabolic pathways in cancer development and the response to treatment.
    Halama A
    Arch Biochem Biophys; 2014 Dec; 564():100-9. PubMed ID: 25218088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
    Pathania D; Millard M; Neamati N
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming.
    Eng CH; Abraham RT
    Oncogene; 2011 Nov; 30(47):4687-96. PubMed ID: 21666712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy, stress, and cancer metabolism: what doesn't kill you makes you stronger.
    Mathew R; White E
    Cold Spring Harb Symp Quant Biol; 2011; 76():389-96. PubMed ID: 22442109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.